Kcentra 1,000 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSQQ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,009
Award facts
- Contract value 100% obligated
- $17,008.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,008.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of 1,000 unit vials of Kcentra. The delivery order, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, operates under a firm fixed-price contract structure with no set-aside designation. DMS Pharmaceutical Group Inc. is performing at its Park Ridge, Illinois location and was selected based on competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion governmentwide acquisition strategy. The prime vendor contract, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional pharmaceutical supplier supporting Department of Defense healthcare operations globally. Kcentra, a prothrombin complex concentrate used for urgent reversal of warfarin anticoagulation, represents one of the critical specialty pharmaceutical products supplied through this contract to military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FSQQ9?
SPE2DR26FSQQ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FSQQ9 worth?
The government has obligated $17,009 on SPE2DR26FSQQ9.
Is contract SPE2DR26FSQQ9 an order under another contract?
Yes. SPE2DR26FSQQ9 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQQ9 competed?
The extent of competition for SPE2DR26FSQQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award